These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36344171)

  • 1. The inflammasomes and immunometabolism: A small molecule inhibitor of the NLRP3 inflammasome.
    Takatsu K
    Biochem Biophys Res Commun; 2022 Dec; 633():84-87. PubMed ID: 36344171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.
    Próchnicki T; Latz E
    Cell Metab; 2017 Jul; 26(1):71-93. PubMed ID: 28683296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
    Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome.
    Zhang T; Ding S; Wang R
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.
    Vong CT; Tseng HHL; Yao P; Yu H; Wang S; Zhong Z; Wang Y
    Drug Discov Today; 2021 Jun; 26(6):1394-1408. PubMed ID: 33636340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease.
    Bai H; Zhang Q
    Front Immunol; 2021; 12():701282. PubMed ID: 34381452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: NLRP3 activation and regulation in innate immune responses.
    Mortellaro A
    Front Immunol; 2023; 14():1171138. PubMed ID: 36969225
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity.
    Alijagic A; Hedbrant A; Persson A; Larsson M; Engwall M; Särndahl E
    Front Immunol; 2023; 14():1178434. PubMed ID: 37143682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Front Immunol; 2020; 11():618231. PubMed ID: 33603747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.
    Rajamäki K; Nordström T; Nurmi K; Åkerman KE; Kovanen PT; Öörni K; Eklund KK
    J Biol Chem; 2013 May; 288(19):13410-9. PubMed ID: 23530046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
    Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
    Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting the NLRP3 Inflammasome.
    El-Sharkawy LY; Brough D; Freeman S
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33255820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NLRP3 inflammasome regulates adipose tissue metabolism.
    Barra NG; Henriksbo BD; Anhê FF; Schertzer JD
    Biochem J; 2020 Mar; 477(6):1089-1107. PubMed ID: 32202638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases.
    Zhang Y; Yang W; Li W; Zhao Y
    Front Immunol; 2021; 12():732933. PubMed ID: 34707607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of the NLRP3 inflammasome].
    Groslambert M; Py BF
    Med Sci (Paris); 2018 Jan; 34(1):47-53. PubMed ID: 29384096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo.
    Li S; Kang P; Zhang W; Jian Z; Zhang Q; Yi X; Guo S; Guo W; Shi Q; Li B; He Y; Song P; Liu L; Li K; Wang G; Gao T; Li C
    J Allergy Clin Immunol; 2020 Feb; 145(2):632-645. PubMed ID: 31756352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.